Clinical Trial Update: Is the WHO Recommended Dose of Pralidoxime Effective in the Treatment of Organophosphorus Poisoning? [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether the WHO-recommended dose of pralidoxime is effective for treating organophosphate poisoning; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organophosphate Poisoning

Drugs mentioned

• Pralidoxime (pralidoxime)

Snippet

Sponsor: Sheri Kashmir Institute of Medical Sciences | Conditions: Deaths | Phase 1 | Status: COMPLETED